Search Results
Found 1228 results for ""
colorectal_landing_getting results@2x
attachment
Colorectal landing_colorectal cancer@2x
attachment
Contact Us
page
Colorectal landing page_getting screened@3x
attachment
Colorectal landing_main photo@3x
attachment
Colorectal
page
ACRCSP-Physician-FAQs-About-FIT Nov 2014
attachment
Alberta Colorectal Cancer Screening Program Physician Commonly Asked Questions about the Fecal Immunochemical Test (FIT) The Fecal Immunochemical Test (FIT) is available province wide. It is now the primary colorectal cancer (CRC) screening modality for average risk individuals, replacing the guaiac Fecal Occult Blood Test (gFOBT) and colonoscopy for average-risk…
ACRCSP When to use FIT flow chart Nov 2016
attachment
Alberta Colorectal Cancer Screening Program When to use the Fecal Immunochemical Test (FIT) Is your asymptomatic patient… Average risk: Age 50-74 Increased risk No personal or family history of polyps or colorectal cancer (crc) Family History: crc and/or high risk adenomas acrcsp advises your patient is screened with High risk…
ACRCSP Standards and Guidelines for Screening Colonoscopy Services Feb 2014
attachment
Alberta Health Services Standards and Guidelines for Screening Colonoscopy Services Alberta Colorectal Cancer Screening Program 2014 Version: 2.0 Updated: February 28, 2014 Contributions This document was a collaborative effort undertaken by the Alberta Colorectal Cancer Screening Program (ACRCSP) over a timeframe of three years. This document is a compilation of…
ACRCSP Recommendations for Antithrombotic Management Poster April 2015
attachment
Suggested Management of Antithrombotic Agents for a Screening-Related Colonoscopy Antithrombotic Agent Recommended interval between last dose and procedure Recommended interval between procedure and next dose If therapeutic intervention performed* Anticoagulant agent Coumadin® (warfarin) Low molecular weight heparin (LMWH)** Pradaxa® (dabigatran) (Predominantly renal excretion. Assessment of renal function is essential) 5d…